688656.SS SHH
HOB Biotech Group Corp.,Ltd
1W: +12.1%
1M: +36.6%
3M: +26.6%
YTD: -7.5%
1Y: +17.7%
3Y: +288.9%
5Y: +71.8%
¥131.72 ($19.65)
-0.31 (-0.23%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥8.4B ($1.2B)
52W Range76.62-217
Volume805,088
Avg Volume737,899
Beta-0.28
Dividend¥0.20
Analyst Ratings
No analyst coverage
Company Info
CEOJohn Li
Employees525
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-01-13
Websitehobiotech.com
No. 9, Dongyanli Road
Suzhou, JS 215009
CN
Suzhou, JS 215009
CN
86 512 6956 1996
About HOB Biotech Group Corp.,Ltd
HOB Biotech Group Corp.,Ltd. is an international in vitro diagnostics firm, active in both China and various global markets. It supplies advanced diagnostic assays, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immunoassays, to laboratories and hospitals. This endeavor aims to improve the treatment and care for patients afflicted with allergies and autoimmune diseases. The company was established in 2009 and is headquartered in Suzhou, China.
Latest News
No recent news
Recent Insider Trades
No insider trades found